Two Sigma Advisers
ACET icon

Two Sigma Advisers’s Adicet Bio ACET Stock Holding History

Two Sigma Advisers’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-111,336
Closed -$937K – 20
2025
Q4 		$937K Buy
111,336
+62,525
+128% +$691K ﹤0.01% 1505
2025
Q3 		$633K Buy
48,811
+13,434
+38% +$158K ﹤0.01% 1666
2025
Q2 		$345K Sell
35,377
-3,550
-9% -$37.4K ﹤0.01% 1907
2025
Q1 		$470K Sell
38,927
-10,700
-22% -$153K ﹤0.01% 1804
2024
Q4 		$764K Buy
49,627
+5,462
+12% +$103K ﹤0.01% 1587
2024
Q3 		$1.02M Buy
44,165
+6,344
+17% +$142K ﹤0.01% 1405
2024
Q2 		$732K Buy
37,821
+6,194
+20% +$166K ﹤0.01% 1718
2024
Q1 		$1.19M Sell
31,627
-875
-3% -$36.2K ﹤0.01% 1494
2023
Q4 		$983K Buy
32,502
+8,333
+34% +$182K ﹤0.01% 1657
2023
Q3 		$530K Buy
24,169
+17,619
+269% +$622K ﹤0.01% 1773
2023
Q2 		$255K Buy
6,550
+781
+14% +$68.9K ﹤0.01% 2032
2023
Q1 		$532K Sell
5,769
-5,562
-49% -$698K ﹤0.01% 1921
2022
Q4 		$1.62M Sell
11,331
-1,838
-14% -$459K ﹤0.01% 1344
2022
Q3 		$3M Sell
13,169
-4,800
-27% -$1.22M 0.01% 979
2022
Q2 		$4.2M Buy
17,969
+725
+4% +$159K 0.01% 855
2022
Q1 		$5.51M Buy
17,244
+2,888
+20% +$664K 0.01% 764
2021
Q4 		$4.02M Buy
14,356
+9,913
+223% +$1.7M 0.01% 863
2021
Q3 		$557K Sell
4,443
-2,406
-35% -$298K ﹤0.01% 1883
2021
Q2 		$1.13M Buy
6,849
+2,075
+43% +$423K ﹤0.01% 1582
2021
Q1 		$999K Buy
4,774
+2,900
+155% +$666K ﹤0.01% 1651
2020
Q4 		$421K Sell
1,874
-661
-26% -$135K ﹤0.01% 1929
2020
Q3 		$482K Buy
2,535
+14
+0.6% +$3.54K ﹤0.01% 1840
2020
Q2 		$607K Buy
2,521
+136
+6% +$26.7K ﹤0.01% 1801
2020
Q1 		$275K Buy
+2,385
New +$354K ﹤0.01% 2049

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Two Sigma Advisers's ACET Position: Q1 2026 in Review

Two Sigma Advisers sold out of Adicet Bio (ACET) in Q1 2026, closing a stake of 111,336 shares — an estimated $937K sold.

Two Sigma Advisers first reported a position in ACET in Q1 2020 and held it in 24 quarters. The position peaked at $5.51M in Q1 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Two Sigma Advisers reported no remaining Adicet Bio position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 111,336 Adicet Bio shares in Q1 2026, an estimated $937K.
  • Two Sigma Advisers first reported a position in Adicet Bio in Q1 2020 and held it in 24 quarters.
  • Two Sigma Advisers's Adicet Bio position peaked at $5.51M in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.